Table II.
Formulation Code | F0 | F1 | F2 | F3 | F4 | F5 |
---|---|---|---|---|---|---|
Formulation Type | Solid Lipid Nanoparticles (SLNs) (%w/v) | Film (%w/w) | ||||
δ8-THC | 0.1 | 0.75 | 0.75 | 0.75 | 0.75 | 20 |
Precirol | 3 | |||||
Compritol | 3 | 3 | 3 | 3 | ||
Glycerine | 2.25 | 2.25 | 2.25 | 2.25 | 2.25 | |
Tween 80 | 0.75 | 0.75 | 0.75 | 0.75 | 0.75 | |
Poloxamer 188 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | |
RMßCD |
3 (In aqueous Phase) |
3 (THC-CD complex) |
||||
HPMC 4k | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | |
PEO N10 | 80 | |||||
IPBS (mL) | q.s | q.s | q.s | q.s | q.s |